Skip to content

Author

Xiao-Kun Geng

We have 4 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Association between the Triglyceride-Glucose Index and Clinical Outcomes in Acute Atherosclerotic Ischaemic Stroke Patients Following Endovascular Thrombectomy: A Retrospective Cohort Study.

BACKGROUND We aimed to investigate the association between the triglyceride-glucose (TyG) index and unfavourable clinical outcomes in patients with atherosclerotic acute ischaemic stroke (AIS) undergoing endovascular thrombectomy (EVT). METHODS Patients with AIS who underwent EVT between January 2019 and September 20...

Feng-Li Che, Zhen-Zhen Han, An-Xin Wang et al. · 0 citations
Open access Sep 2026

Stroke severity–dependent prognostic value of the C-reactive protein–triglyceride glucose index after acute ischemic stroke

Functional outcomes after acute ischemic stroke vary substantially among patients with similar neurological deficit severity, suggesting that factors beyond acute injury burden contribute to recovery. Metabolic–inflammatory dysregulation represents a chronic host condition that may influence the poststroke recove...

Lin-Lin Ma, Lang Ji, Chuan-Jie Wu et al. · 0 citations
Review Open access Sep 2026

Single-cell and single-nucleus transcriptomics in ischemic stroke: cellular mechanisms and therapeutic implications

This review systematically integrates current evidence from sc/snRNA-seq studies, with a primary focus on brain-intrinsic mechanisms after ischemic stroke, to provide a structured synthesis of how sc/snRNA-seq has advanced the understanding of ischemic stroke biology.

Chang-Qing Mu, Yu-Chuan Ding, Alexander Weiss et al. · 0 citations
#diffusion models Review Open access Aug 2026

Carbon dots as a smart nanoplatform for the blood‐brain barrier penetration and ischemic stroke therapy

Ischemic stroke (IS) is one of the primary causes of global mortality and permanent neurological disability, and its clinical treatment is severely constrained by the intricate ischemic pathological cascade and the impermeable blood‐brain barrier (BBB). Cerebral ischemia and reperfusion trigger a series of pathologic...

Yan-Han Huang, Xuan Hou, Haiping Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.